Putting children first - Why paediatric clinical trials must be conducted

Pharmaceutical Journal

Volumn 269, Issue 7228, 2002, Pages 843-

  Cheung, Chi Loon ^a   Sung, Seau Tak ^a   Persaud, John ^a  

^a BIRMINGHAM CHILDREN S HOSPITAL NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CHLORAMPHENICOL; PROPOFOL;

AGE; BLOOD SAMPLING; CHILD CARE; CHILDHOOD DISEASE; CLINICAL RESEARCH; CLINICAL STUDY; DRUG DOSAGE FORM; DRUG EFFICACY; DRUG FORMULATION; DRUG MARKETING; DRUG METABOLISM; DRUG MONITORING; DRUG SAFETY; EVIDENCE BASED MEDICINE; HEALTH CARE NEED; HUMAN; KIDNEY FUNCTION; LICENSING; LIVER FUNCTION; NOTE; PEDIATRICS; PHARMACOKINETICS;

EID: 0037079474     PISSN: 00316873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Note

References (6)

1. Conroy S, Choonara I, Impicciatore P, et al. Survey of unlicensed and off label drug use in paediatric wards in European countries. BMJ 2000;320:70-82.
2. Bailey B, Klein J, Koren G. Non-invasive methods for drug measurement in pediatrics. Pediatr Clin North Am 1997;44:15-26.
3. European Commission. Better medicines for Children, Brussels: The Commission; 2002.
4. Modern regulatory environment shaped by pediatric pharmacology. Brown University Child and Adolescent Pyschopharmacology Update 2002;4(5):2-3.
5. Sutherland JM. Fatal cardiovascular collapse of infants receiving large amounts of chloramphenicol. Am J Dis Child 1959;97:761-7.
6. Hatch DJ. Propofol-infusion syndrome in children. Lancet 1999; 353:117-8.